Close COVID Vaccine Plant in Germany Threatens 1860 Jobs
BioNTech, the German company known for developing one of the first mRNA COVID vaccines, announced a complete halt to its vaccine production, endangering approximately 1860 jobs. This decision is part of a restructuring effort to focus on research and treatment of other diseases.